3 Reasons Why You Should Invest in Well Health (TSX:WELL) Stock

Here’s why investing in Well Health Technologies (TSX:WELL) stock will help you beat the market.

| More on:
A person suffering

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

While most sectors are struggling amid the COVID-19 pandemic, a few have been immune to the coronavirus. For example, companies in the pharma and technology space have managed to outperform the broader markets.

Here we look at one of the most promising health-tech stocks on the TSX that is well poised to generate multi-fold returns over the upcoming decade.

Well Health Technologies has grown at an impressive pace

Shares of Well Health Technologies (TSX:WELL) are trading at $6.17 and has gained over 300% in 2020. The stock went public back in April 2016 and has returned a staggering 5,500% in less than five years. This means a $1,000 investment in Well Health stock soon after its IPO would have returned over $56,000 today.

Well Health aims to leverage technology to support patients and doctors. In British Columbia, it owns 19 medical clinics with 180 physicians and provides SaaS services to support a network of 1,900 medical clinics supporting 10,000 physicians and 15 million patients in Canada

Its acquisitions of EMR (electronic medical record) service providers have made Well Health the third-largest company in this space. It March 2020, the company launched its telehealth service called VirtualClinic+ which is a digital health communications platform that connects patients and physicians via video, messaging, and phone.

In a nutshell, Well Health wants to consolidate and modernize primary healthcare assets by leveraging digital technologies and processes which will improve patient experience and operational efficiency.

Focus on acquisitions

Well Health has focused on inorganic growth to expand its top line. It has completed several acquisitions since the start of 2018 including three equity investments. The company’s clinical portfolio acquisitions include six clinics in February 2018, 13 clinics in November 2018, and majority stakeholder positions in SleepWorks and Spring Medical in 2019.

Well Health has confirmed it will continue to actively pursue acquisition opportunities within the clinical and digital healthcare marketplaces.

Huge potential for long-term growth

According to Well Health, the Canadian care delivery sector is valued at $253 billion, with physician spending accounting for 15.4% of this market. While the healthcare space is plagued by operational challenges, which include a highly fragmented market and lack of technology, it provides Well Health to add value by aiding the digital transformation processes.

Well Health believes the industry is ripe for disruption and stands to benefit from “an active consolidator that can help its technological and fragmentation problems.”

Well Health has managed to increase sales from $7.95 million in 2018 to $32 million in 2019. It is expected to touch $44.6 million in 2020 and $68.5 million in 2021. Well Health is valued at a market cap of $808 million which means its forward price to sales multiple is 18.11 which might be considered sky-high. However, investors should also note that the company continues to grow at a rapid pace and should be profitable by the end of 2022.

I had first recommended Well Health Technologies in January 2020 when the stock was trading at $1.84 per share. It has since gained 235% and remains a long-term buy considering it wants to disrupt the traditional healthcare space.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »